Free Trial

Dark Forest Capital Management LP Sells 94,526 Shares of Azenta, Inc. (NASDAQ:AZTA)

Azenta logo with Medical background

Dark Forest Capital Management LP lessened its holdings in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 90.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,011 shares of the company's stock after selling 94,526 shares during the period. Dark Forest Capital Management LP's holdings in Azenta were worth $501,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of AZTA. Picton Mahoney Asset Management grew its holdings in Azenta by 305.7% in the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock worth $35,000 after purchasing an additional 532 shares during the period. Headlands Technologies LLC bought a new stake in shares of Azenta in the 4th quarter worth approximately $40,000. Covestor Ltd grew its stake in shares of Azenta by 64.2% in the 4th quarter. Covestor Ltd now owns 2,043 shares of the company's stock worth $102,000 after buying an additional 799 shares during the last quarter. KBC Group NV increased its position in Azenta by 48.5% during the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after buying an additional 698 shares in the last quarter. Finally, Sterling Capital Management LLC raised its stake in Azenta by 39.8% during the fourth quarter. Sterling Capital Management LLC now owns 2,856 shares of the company's stock valued at $143,000 after buying an additional 813 shares during the last quarter. 99.08% of the stock is currently owned by institutional investors.

Azenta Stock Performance

Shares of AZTA traded up $0.64 during mid-day trading on Friday, hitting $26.87. 232,955 shares of the company traded hands, compared to its average volume of 650,535. The stock has a market cap of $1.23 billion, a price-to-earnings ratio of -9.03 and a beta of 1.66. The stock has a 50-day moving average price of $33.54 and a two-hundred day moving average price of $42.75. Azenta, Inc. has a 1 year low of $24.06 and a 1 year high of $63.58.

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. On average, analysts forecast that Azenta, Inc. will post 0.53 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on AZTA shares. TD Cowen raised Azenta to a "hold" rating in a research note on Thursday, February 27th. Needham & Company LLC increased their price objective on shares of Azenta from $55.00 to $59.00 and gave the company a "buy" rating in a research report on Thursday, February 6th. Stephens reaffirmed an "overweight" rating and issued a $60.00 target price on shares of Azenta in a report on Thursday, January 2nd. Finally, Evercore ISI increased their price target on shares of Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a report on Thursday, February 6th.

Get Our Latest Stock Analysis on AZTA

Azenta Profile

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

See Also

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Should You Invest $1,000 in Azenta Right Now?

Before you consider Azenta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.

While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines